Genomic Signatures of the Haarlem Lineage of Mycobacterium tuberculosis : Implications of Strain Genetic Variation in Drug and Vaccine Development
Open Access
- 1 October 2010
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (10), 3614-3623
- https://doi.org/10.1128/jcm.00157-10
Abstract
Tuberculosis is the world's leading cause of death due to a single infectious agent, and efforts aimed at its control require a better understanding of host, environmental, and bacterial factors that govern disease outcome. Growing evidence indicates that certain Mycobacterium tuberculosis strains of distinct phylogeographic lineages elicit unique immunopathological events. However, identifying the genetic basis of these phenotypic peculiarities has proven difficult. Here we report the presence of six large sequence polymorphisms which, together with two single-nucleotide changes previously described by our group, consistently differentiate Haarlem strains from the remaining M. tuberculosis lineages. The six newly found Haarlem-specific genetic events are four deletions, which altogether involve more than 13 kb, and two intragenic insertions of the element IS 6110 . The absence of the genes involved in these polymorphisms could have an important physiological impact on Haarlem strains, i.e., by affecting key genes, such as Rv1354c and cyp121 , which have been recently proposed as plausible drug targets. These lineage-specific polymorphisms can serve as genetic markers for the rapid PCR identification of Haarlem strains, providing a useful tool for strain surveillance and molecular epidemiology studies. Strain variability such as that described here underscores the need for the definition of a core set of essential genes in M. tuberculosis that are ubiquitously present in all circulating lineages, as a requirement in the development of effective antituberculosis drugs and vaccines.Keywords
This publication has 31 references indexed in Scilit:
- Virulence, immunopathology and transmissibility of selected strains ofMycobacterium tuberculosisin a murine modelImmunology, 2009
- Uncovering new signaling proteins and potential drug targets through the interactome analysis of Mycobacterium tuberculosisBMC Genomics, 2009
- High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human DemographyPLoS Biology, 2008
- Characterization of Active Site Structure in CYP121: A Cytochrome P450 Essential for Viability of Mycobacterium Tuberculosis H37Rv*Journal of Biological Chemistry, 2008
- Relationship between Mycobacterium tuberculosis Genotype and the Clinical Phenotype of Pulmonary and Meningeal TuberculosisJournal of Clinical Microbiology, 2008
- Analysis of the genetic variation in Mycobacterium tuberculosis strains by multiple genome alignmentsBMC Research Notes, 2008
- Mutations in DNA repair genes are associated with the Haarlem lineage of Mycobacterium tuberculosis independently of their antibiotic resistanceTuberculosis, 2007
- Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?Immunological Reviews, 2007
- Evidence for Recombination inMycobacterium tuberculosisJournal of Bacteriology, 2006
- Molecular Epidemiology of Tuberculosis: Current InsightsClinical Microbiology Reviews, 2006